Cardiol Therapeutics Inc logo

Cardiol Therapeutics Inc - Class A

TSX:CRDL (Canada)   Class A
C$ 2.43 (-2.8%) Mar 28
At Loss
P/B:
4.65
Market Cap:
C$ 158.23M ($ 116.76M)
Enterprise V:
C$ 117.87M ($ 86.98M)
Volume:
102.08K
Avg Vol (2M):
185.08K
Also Trade In:
Volume:
102.08K
At Loss
Avg Vol (2M):
185.08K
Market Cap C$ M 158.23
Enterprise Value C$ M 117.87
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book 4.65
Price/Sales --
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) C$ M --
EPS (TTM) C$ -0.43
Beneish M-Score 0
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % -38.10
y-y EBITDA Growth Rate % --
EV-to-EBIT -3.82
EV-to-EBITDA -3.85
PEG --
Shares Outstanding M 65.11
Net Margin (%) --
Operating Margin % --
Pre-tax Margin (%) --
Quick Ratio 5.29
Current Ratio 5.29
ROA % (ttm) -51.24
ROE % (ttm) -60.87
ROIC % (ttm) -1,966.35
Dividend Yield % --
Altman Z-Score --
Piotroski F-Score 1.00
Positive ROA N
Positive CFROA N
Higher ROA y-y Y
Cash flow > Earnings N
Lower Leverage y-y N
Higher Current Ratio y-y N
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y N

TSX:CRDL Number of Guru Trades

To

TSX:CRDL Volume of Guru Trades

To

Gurus Latest Trades with TSX:CRDL

No Available Data

TSX:CRDL is held by these investors

No Available Data

Cardiol Therapeutics Inc Insider Transactions

No Available Data